Serum Levels of Soluble Syndecan-1 in Hodgkin's Lymphoma
Background: Syndecan-1 (CD138) is expressed by the Hodgkin-Reed-Sternberg (HRS) cells of classic Hodgkin's lymphoma (cHL), but not in nodular lymphocyte-predominant HL. Syndecan-1 may be involved in the interaction between HRS cells and the cellular and stromal microenvironment typical of nodul...
Gespeichert in:
Veröffentlicht in: | Anticancer research 2005-11, Vol.25 (6C), p.4743-4746 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background: Syndecan-1 (CD138) is expressed by the Hodgkin-Reed-Sternberg (HRS) cells of classic Hodgkin's lymphoma (cHL),
but not in nodular lymphocyte-predominant HL. Syndecan-1 may be involved in the interaction between HRS cells and the cellular
and stromal microenvironment typical of nodular sclerosing HL. Patients and Methods: Serum levels of soluble syndecan-1 were
determined by ELISA in 66 patients with HL and 14 age- and sex-matched healthy individuals. Results: The levels of syndecan-1
were higher in HL patients than controls (100.2±35.9 ng/ml vs. 67.9±24.5 ng/ml, p |
---|---|
ISSN: | 0250-7005 1791-7530 |